Insilico Medicine completes first-in-patient dosing of ISM3412, the novel MAT2A inhibitor for the treatment of locally advanced/metastatic solid tumors - EurekAlert!
Insilico Medicine completes oversubscribed Series E, bringing total funding around $123 million - EurekAlert!
Insilico Medicine announces Nature Medicine publication of Phase IIa results evaluating rentosertib, the novel TNIK inhibitor for idiopathic pulmonary fibrosis (IPF) discovered and designed with a pioneering AI approach - EurekAlert!
Insilico Medicine and collaborator announce discovery of potent WDR5-MYC interaction inhibitors through generative AI platform - EurekAlert!
Pharma.AI Day 2025: Register now! Insilico Medicine to unveil gen-AI platform quarterly updates on April 24 - EurekAlert!
Booth #5A14｜Meet Insilico Medicine at Abu Dhabi Global Health Week - EurekAlert!
Insilico Medicine deploys the first bipedal humanoid AI scientist in the fully-robotic drug discovery laboratory - EurekAlert
Insilico Medicine successfully delivered mile - EurekAlert
Harbour BioMed and Insilico Medicine achieve - EurekAlert
Menarini Group and Insilico Medicine enter a - EurekAlert
Insilico Medicine received first clinical milestone payment from Exelixis - EurekAlert
Insilico Medicine recognized by Endeavor Vent - EurekAlert
Leading the era of AI changes, Insilico Medicine is proudly listed in fortune 50 AI innovators - EurekAlert
Insilico Medicine receives IND clearance from FDA for ISM5939, an oral ENPP1 inhibitor treating solid tumors - EurekAlert
Insilico Medicine announces Pharma.AI week we - EurekAlert
Insilico Medicine announces positive topline - EurekAlert
Insilico Medicine enters into revolving loan facility of up to US$100 Million with HSBC - EurekAlert
Insilico Medicine achieves a milestone in AI-facilitated drug discovery collaboration with Sanofi - EurekAlert
Insilico Medicine appoints Carol Satler, MD. - EurekAlert
Insilico Medicine reports positive Phase IIa results for ISM001-055, a novel first-in-class drug treatment for idiopathic pulmonary fibrosis (IPF) designed using generative AI - EurekAlert
